Sonoma pharmaceuticals posts qtrly loss per share of $0.91

Sonoma pharmaceuticals reports second quarter fy 2020 financial results.q2 revenue rose 1 percent to $4.968 million.qtrly loss per share $0.91.
SNOA Ratings Summary
SNOA Quant Ranking